These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15123273)

  • 1. Finding Cinderella after the ball: a three-hybrid approach to drug target identification.
    Lefurgy S; Cornish V
    Chem Biol; 2004 Feb; 11(2):151-3. PubMed ID: 15123273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yeast "N"-hybrid systems for protein-protein and drug-protein interaction discovery.
    Rezwan M; Auerbach D
    Methods; 2012 Aug; 57(4):423-9. PubMed ID: 22728036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between ligand-receptor affinity and the transcription readout in a yeast three-hybrid system.
    de Felipe KS; Carter BT; Althoff EA; Cornish VW
    Biochemistry; 2004 Aug; 43(32):10353-63. PubMed ID: 15301533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affordable proteomics: the two-hybrid systems.
    Gillespie M
    Curr Opin Mol Ther; 2003 Jun; 5(3):266-70. PubMed ID: 12870436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of protein interactions by yeast two-hybrid screening and coimmunoprecipitation.
    Tanowitz M; von Zastrow M
    Methods Mol Biol; 2004; 259():353-69. PubMed ID: 15250504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of genes for proteins interacting with the PS1TP5 protein of hepatitis B virus: probing a human leukocyte cDNA library using the yeast two-hybrid system.
    Zhang JK; Zhao LF; Cheng J; Guo J; Lun YZ; Hong Y
    Chin Med J (Engl); 2006 Nov; 119(22):1884-91. PubMed ID: 17134587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-target identification in Drosophila cells: combining high-throughout RNAi and small-molecule screens.
    Perrimon N; Friedman A; Mathey-Prevot B; Eggert US
    Drug Discov Today; 2007 Jan; 12(1-2):28-33. PubMed ID: 17198970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures.
    Bickle MB; Dusserre E; Moncorgé O; Bottin H; Colas P
    Nat Protoc; 2006; 1(3):1066-91. PubMed ID: 17406388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A library approach for the discovery of customized yeast three-hybrid counter selections.
    Wingler LM; Cornish VW
    Chembiochem; 2011 Mar; 12(5):715-7. PubMed ID: 21404416
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo selection of intrabodies specifically targeting protein-protein interactions: a general platform for an "undruggable" class of disease targets.
    Visintin M; Melchionna T; Cannistraci I; Cattaneo A
    J Biotechnol; 2008 May; 135(1):1-15. PubMed ID: 18395925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist.
    Chen Q; Chen J; Sun T; Shen J; Shen X; Jiang H
    Anal Biochem; 2004 Dec; 335(2):253-9. PubMed ID: 15556564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A yEGFP-based reporter system for high-throughput yeast two-hybrid assay by flow cytometry.
    Chen J; Zhou J; Bae W; Sanders CK; Nolan JP; Cai H
    Cytometry A; 2008 Apr; 73(4):312-20. PubMed ID: 18307271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology calls the targets: combining RNAi and disease biology.
    van Es HH; Arts GJ
    Drug Discov Today; 2005 Oct; 10(20):1385-91. PubMed ID: 16253877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The topology of drug-target interaction networks: implicit dependence on drug properties and target families.
    Mestres J; Gregori-Puigjané E; Valverde S; Solé RV
    Mol Biosyst; 2009 Sep; 5(9):1051-7. PubMed ID: 19668871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-hybrid technologies in proteomics research.
    Suter B; Kittanakom S; Stagljar I
    Curr Opin Biotechnol; 2008 Aug; 19(4):316-23. PubMed ID: 18619540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The yeast two-hybrid system and its role in drug discovery.
    Lentze N; Auerbach D
    Expert Opin Ther Targets; 2008 Apr; 12(4):505-15. PubMed ID: 18348685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seeing small molecules in action with bioorthogonal chemistry.
    Raghavan AS; Hang HC
    Drug Discov Today; 2009 Feb; 14(3-4):178-84. PubMed ID: 18973827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of TMEM87B interacting with the human papillomavirus type 18 E6 oncogene in the Hela cDNA library by a yeast two-hybrid system.
    Li S; Liu P; Xi L; Jiang X; Wu M; Deng D; Wei J; Zhu T; Zhou L; Wang S; Xu G; Meng L; Zhou J; Ma D
    Oncol Rep; 2008 Aug; 20(2):421-7. PubMed ID: 18636207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.